Freeline Therapeutics
Freeline is a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases.
Org chart
Teams
View all
Discover similar companies
Cytodyn
Vancouver, United States · Post IPO Equity
Ultivue
Cambridge, United States · Series D
Adaptive Phage Therapeutics
Gaithersburg, United States · Grant
Regeneron
Tarrytown, United States · Post IPO Equity
Be Bio
Cambridge, United States · Series B
Verve Therapeutics
Cambridge, United States · IPO
Biogen
Cambridge, United States
Century Therapeutics
Philadelphia, United States · Post IPO Equity
Guardant Health
Redwood City, United States · Venture
Genentech
South San Francisco, United States · Venture
Natera
Austin, United States · Post IPO Equity
Biomason
Durham, United States · Series C
helps you hire
great candidates
It’s free to use - try it out today.